P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates

Peters, 1987

Jones, 1958, Mass treatment with pyrimethamine. A study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya, September 1952–September 1953, Trans R Soc Trop Med Hyg, 52, 547, 10.1016/0035-9203(58)90104-4

1990

Radloff, 1996, Atovaquone and proguanil for Plasmodium falciparum malaria, Lancet, 347, 1511, 10.1016/S0140-6736(96)90671-6

Amukoye, 1997, Chlorproguanildapsone: an effective treatment for uncomplicated falciparum malaria, Antimicrob Agents Chemother, 41, 2261, 10.1128/AAC.41.10.2261

Rieckmann, 1996, Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model, Trans R Soc Trop Med Hyg, 90, 568, 10.1016/S0035-9203(96)90326-0

Plowe, 1995, Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa, Am J Trop Med Hyg, 52, 565, 10.4269/ajtmh.1995.52.565

Nguyen-Dinh, 1980, Pyrimethamine sensitivity in Plasmodium falciparum: determination in vitro by a modified 48-hour test, Bull World Health Organ, 58, 909

Triglia, 1998, The mechanism of resistance to sulfa drugs in Plasmodium falciparum, Drug Resistance Updates

Sirawaraporn, 1998, Dihydrofolate reductase and antifolate resistance in malaria, Drug Resistance Updates, 1, 397, 10.1016/S1368-7646(98)80015-0

Peterson, 1988, Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria, 85, 9114

Cowman, 1988, Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum, 85, 9109

Snewin, 1989, Characterisation of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine, Gene, 76, 41, 10.1016/0378-1119(89)90006-1

Zolg, 1989, Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum, Mol Biochem Parasitol, 36, 253, 10.1016/0166-6851(89)90173-4

Peterson, 1990, Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria, 87, 3018

Foote, 1990, Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance, 87, 3014

Brooks, 1994, Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine, Eur J Biochem, 224, 397, 10.1111/j.1432-1033.1994.00397.x

Triglia, 1994, Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum, 91, 7149

Wang, 1997, Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization, Molec Microbiol, 23, 979, 10.1046/j.1365-2958.1997.2821646.x

Triglia, 1997, Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum, 94, 13944

Wu, 1996, Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine, 93, 1130

Triglia, 1998, Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihyropteroate synthase in sulfadoxine-resistant malaria, EMBO J, 17, 3807, 10.1093/emboj/17.14.3807

Plowe, 1997, Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance, J Infect Dis, 176, 1590, 10.1086/514159

Wang, 1997, Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthase and dihydrofolate reductase alleles in a large number of field samples of diverse origins, Mol Biochem Parasitol, 89, 161, 10.1016/S0166-6851(97)00114-X

Gyang, 1992, Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine, Exp Parasitol, 74, 470, 10.1016/0014-4894(92)90209-S

Duraisingh, 1998, Plasmodium falciparum — detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion, Exp Parasitol, 89, 1, 10.1006/expr.1998.4274

Peterson, 1991, Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon, Am J Trop Med Hyg, 45, 492, 10.4269/ajtmh.1991.45.492

Wang, 1995, A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum, Mol Biochem Parasitol, 71, 115, 10.1016/0166-6851(95)00041-X

Shaio, 1998, Development and comparison of quantitative assays for the dihydropteroate synthetase codon 540 mutation associated with sulfadoxine resistance in Plasmodium falciparum, Parasitology, 116, 203, 10.1017/S0031182097002187

Plowe, 1996, Community pyrimethamine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: A model for deterring resistance, Am J Trop Med Hyg, 55, 467, 10.4269/ajtmh.1996.55.467

Curtis, 1996, Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania, Trans R Soc Trop Med Hyg, 90, 678, 10.1016/S0035-9203(96)90432-0

Edoh, 1997, Pyrimethamine-resistant Plasmodium falciparum parasites among Tanzanian children: A facility-based study using the polymerase chain reaction, Am J Trop Med Hyg, 57, 342, 10.4269/ajtmh.1997.57.342

Nguyen-Dinh, 1982, Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya, Lancet, 1, 823, 10.1016/S0140-6736(82)91873-6

Schapira, 1986, The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results, Am J Trop Med Hyg, 35, 239, 10.4269/ajtmh.1986.35.239

Watkins, 1997, The efficacy of antifolate antimalarial combinations in Africa: A predictive model based on pharmadocynamic and pharmacokinetic analyses, parasitol Today, 13, 459, 10.1016/S0169-4758(97)01124-1

Chulay, 1984, Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro, Am J Trop Med Hyg, 33, 325, 10.4269/ajtmh.1984.33.325

Krungkrai, 1989, De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum, Mol Biochem Parasitol, 32, 25, 10.1016/0166-6851(89)90126-6

van Hensbroek, 1995, Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria, Trans R Soc Trop Med Hyg, 89, 672, 10.1016/0035-9203(95)90438-7

Marsh, 1992, Malaria- a neglected disease?, Parasitology, 104, S53, 10.1017/S0031182000075247

Baird, 1991, Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia, Am J Trop Med Hyg, 44, 640, 10.4269/ajtmh.1991.44.640

Watkins, 1990, Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults, Trans R Soc Trop Med Hyg, 84, 492, 10.1016/0035-9203(90)90010-C

1984, 711, 29

Plowe, 1996, Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance, Am J Trop Med Hyg, 55, 467, 10.4269/ajtmh.1996.55.467

Diourte, 1998, Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali, Am J Trop Med Hyg

Jelinek, 1997, High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance, Trop Med Int Health, 2, 1075, 10.1046/j.1365-3156.1997.d01-189.x

Basco, 1995, Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum, Mol Biochem Parasitol, 69, 135, 10.1016/0166-6851(94)00207-4

Reeder, 1996, Point mutations in the dihydrofolate reductase and dihydropteroate synthatase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea, Am J Trop Med Hyg, 55, 209, 10.4269/ajtmh.1996.55.209

Basco, 1998, Molecular epidemiology of malaria in Yaounde, Cameroon II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum, Am J Trop Med Hyg, 58, 374, 10.4269/ajtmh.1998.58.374

Basco, 1998, Molecular epidemiology of malaria in Yaounde, Cameroon I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum, Am J Trop Med Hyg, 58, 369, 10.4269/ajtmh.1998.58.369

Zindrou, 1996, Plasmodium falciparum: Mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient, Exp Parasitol, 84, 56, 10.1006/expr.1996.0089

Kublin, 1998, Molecular assays for surveillance of antifolate-resistant malaria, Lancet, 351, 1629, 10.1016/S0140-6736(98)24022-0

Cortese, 1998, Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutants expressed in yeast, Mol Biochem Parasitol, 94, 205, 10.1016/S0166-6851(98)00075-9

Clyde, 1957, Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals, Trans R Soc Trop Med Hyg, 51, 505, 10.1016/0035-9203(57)90039-1

Watkins, 1993, Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life, Trans R Soc Trop Med Hyg, 87, 75, 10.1016/0035-9203(93)90431-O

Schultz, 1994, The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi, Am J Trop Med Hyg, 51, 515, 10.4269/ajtmh.1994.51.515

Curtis, 1998, In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanildapsone treatment, J Infect Dis, 177, 1429, 10.1086/517831

Sirawaraporn, 1997, Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase, 94, 1124

Paul, 1995, Mating patterns in malaria parasite populations of Papua New Guinea, Science, 269, 1709, 10.1126/science.7569897

Mackinnon, 1997, Survival probability of drug resistant mutants in malaria parasites, 53

Pablos-Mendez, 1998, Global surveillance for antituberculosis-drug resistance, 1994–1997, N Engl J Med, 338, 1641, 10.1056/NEJM199806043382301